Copyright information:Taken from "Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients"BMC Cancer 2006;6():183-183.Published online 11 Jul 2006PMCID:PMC1539015. , ovarian cancer cell lines; , patient-derived ovarian cancer cells. Cells were incubated with SAHA or paclitaxel for 72 hours, and cytotoxic effects were assessed by Alamar Blue assay. Cell viabilities are expressed as the ratio of absorbance of treated to untreated cells. Means ± SD of 2 (ASC-OC-1), 3 (ASC-OC-2 to ASC-OC-5), or 4 (cell lines) independent experiments in quadruplicates are shown.